Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Achieve Life Sciences Inc’s stock clocked out at $4.78, down -2.05% from its previous closing price of $4.88. In other words, the price has decreased by -$2.05 from its previous closing price. On the day, 1.53 million shares were traded. ACHV stock price reached its highest trading level at $5.185 during the session, while it also had its lowest trading level at $4.7.
Ratios:
To gain a deeper understanding of ACHV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.14 and its Current Ratio is at 5.14. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.26.
Upgrades & Downgrades
In the most recent recommendation for this company, Citizens JMP on November 25, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $19.
On August 21, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.
On November 14, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $12.Rodman & Renshaw initiated its Buy rating on November 14, 2024, with a $12 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 18 ’25 when Oki Mark K sold 50,060 shares for $2.92 per share. The transaction valued at 146,175 led to the insider holds 127,940 shares of the business.
Stewart Richard Alistair sold 129,501 shares of ACHV for $378,143 on Sep 18 ’25. The Chief Executive Officer now owns 228,875 shares after completing the transaction at $2.92 per share. On Sep 04 ’25, another insider, Wan Jerry, who serves as the Principal Accounting Officer of the company, sold 14,070 shares for $2.77 each. As a result, the insider received 38,974 and left with 32,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 254458480 and an Enterprise Value of 216302464.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.72, which has changed by 0.07964599 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.78, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is 13.98%, while the 200-Day Moving Average is calculated to be 51.42%.
Shares Statistics:
It appears that ACHV traded 1.29M shares on average per day over the past three months and 650070 shares per day over the past ten days. A total of 52.81M shares are outstanding, with a floating share count of 46.35M. Insiders hold about 12.93% of the company’s shares, while institutions hold 40.04% stake in the company. Shares short for ACHV as of 1763078400 were 6315019 with a Short Ratio of 4.88, compared to 1760486400 on 4735602. Therefore, it implies a Short% of Shares Outstanding of 6315019 and a Short% of Float of 13.850000000000001.
Earnings Estimates
A comprehensive evaluation of Achieve Life Sciences Inc (ACHV) is underway, with the input of 7.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.25 and low estimates of -$0.43.
Analysts are recommending an EPS of between -$1.22 and -$1.3 for the fiscal current year, implying an average EPS of -$1.27. EPS for the following year is -$1.14, with 7.0 analysts recommending between -$0.84 and -$1.37.
